Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Montastruc

Showing results (1-10 of 496) with videos related to

Pageof 50
Sort By:
Therapie|March 4, 2003
[Social pharmacology: a new topic in clinical pharmacology]J L Montastruc
La Revue De Medecine Interne|November 7, 2009
[From pharmacovigilance to pharmacoepidemiology and risk coordination]J-L Montastruc
La Revue Du Praticien|February 1, 1983
[Morphine antagonists]J L Montastruc
Therapie|July 1, 1991
Recent advances in the clinical pharmacology of Parkinson's diseaseJ L Montastruc
La Revue Du Praticien|November 21, 1990
[Parkinsonian syndrome. Etiology, diagnosis, treatment]J L Montastruc
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Treatment of Parkinson's disease should begin with a dopamine agonistJ L Montastruc
La Revue Du Praticien|May 11, 1991
[Serotonin and migraine. Hypothesis with pathogenic and pharmacological implications]J L Montastruc
Revue Neurologique|August 1, 2000
[Role of dopaminergic agonists]O Rascol, J L Montastruc
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Metoclopramide-induced panic attacksH Chabrol, J L Montastruc
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1980
Effect of intracisternal butoxamine, a beta-2 adrenoceptor blocking agent, on blood pressure and heart rate in the dogJ L Montastruc, P Montastruc
Pageof 50

Showing results (1-10 of 496) with videos related to

Sort By:
Pageof 50
Therapie|March 4, 2003
[Social pharmacology: a new topic in clinical pharmacology]J L Montastruc
La Revue De Medecine Interne|November 7, 2009
[From pharmacovigilance to pharmacoepidemiology and risk coordination]J-L Montastruc
La Revue Du Praticien|February 1, 1983
[Morphine antagonists]J L Montastruc
Therapie|July 1, 1991
Recent advances in the clinical pharmacology of Parkinson's diseaseJ L Montastruc
La Revue Du Praticien|November 21, 1990
[Parkinsonian syndrome. Etiology, diagnosis, treatment]J L Montastruc
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Treatment of Parkinson's disease should begin with a dopamine agonistJ L Montastruc
La Revue Du Praticien|May 11, 1991
[Serotonin and migraine. Hypothesis with pathogenic and pharmacological implications]J L Montastruc
Revue Neurologique|August 1, 2000
[Role of dopaminergic agonists]O Rascol, J L Montastruc
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Metoclopramide-induced panic attacksH Chabrol, J L Montastruc
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1980
Effect of intracisternal butoxamine, a beta-2 adrenoceptor blocking agent, on blood pressure and heart rate in the dogJ L Montastruc, P Montastruc
Pageof 50